Upgrade to SI Premium - Free Trial

Merck's (MRK) PIFELTRO and DELSTRIGO Receive FDA Approval for Use in Appropriate Adults Living with HIV-1 Who Are Virologically Suppressed

September 20, 2019 6:46 AM
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles